MidSouth Dermatology /ID# 17128 — Bartlett, Tennessee

MidSouth Dermatology /ID# 17128 is a clinical research site located in Bartlett, Tennessee, United States 38134.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MidSouth Dermatology /ID# 17128 has participated in 1 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bartlett

Browse all research sites in Tennessee · View every site in Bartlett

• University of Tennessee Cancer Institute
• US Oncology - University of Tennessee Cancer Institute - Bartlett
• Saint Francis Hospital-Bartlett
• AM Diabetes and Endocrinology Center
• Boston Baskin Cancer Center-Bartlett
• AM Diabetes & Endocrinology Center
• Pfizer Investigational Site
• Research Site
• Novo Nordisk Investigational Site
• Baptist Cancer Center- Bartlett
• Local Institution
• AM Diabetes & Endocrinology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidSouth Dermatology /ID# 17128?

MidSouth Dermatology /ID# 17128 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidSouth Dermatology /ID# 17128 conducted?

MidSouth Dermatology /ID# 17128 has 1 clinical trials on record. Their work covers Chronic Plaque Psoriasis.

Is MidSouth Dermatology /ID# 17128 accredited by Crixeo Clinical Trials?

MidSouth Dermatology /ID# 17128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidSouth Dermatology /ID# 17128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.